Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.

This study presents a dissolving microneedle patch, composed of starch and gelatin, for the rapid and efficient transdermal delivery of insulin. The microneedles completely dissolve after insertion into the skin for 5 min, quickly releasing their encapsulated payload into the skin. A histological examination shows that the microneedles have sufficient mechanical strength to be inserted in vitro into porcine skin to a depth of approximately 200 μm and in vivo into rat skin to 200-250 μm depth. This penetration depth does not induce notable skin irritation or pain sensation. To evaluate the feasibility of using these dissolving microneedles for diabetes treatment insulin-loaded microneedles were administered to diabetic rats using a homemade applicator. Pharmacodynamic and pharmacokinetic results show a similar hypoglycemic effect in rats receiving insulin-loaded microneedles and a subcutaneous injection of insulin. The relative pharmacological availability and relative bioavailability of insulin were both approximately 92%, demonstrating that insulin retains its pharmacological activity after encapsulation and release from the microneedles. Storage stability analysis confirms that more than 90% of the insulin remained in the microneedles even after storage at 25 or 37°C for 1 month. These results confirm that the proposed starch/gelatin microneedles enable stable encapsulation of bioactive molecules and have great potential for transdermal delivery of protein drugs in a relatively painless, rapid, and convenient manner.

[1]  Mark R Prausnitz,et al.  Kinetics of skin resealing after insertion of microneedles in human subjects. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[2]  W. Hinrichs,et al.  Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities , 2008, Pharmaceutical Research.

[3]  Kanji Takada,et al.  Feasibility of microneedles for percutaneous absorption of insulin. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  M. Prausnitz,et al.  Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. , 2009, Diabetes technology & therapeutics.

[5]  Thomas R Kreil,et al.  Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cells , 2009, Biotechnology journal.

[6]  M. Røder,et al.  Enzyme immunoassay for intact human insulin in serum or plasma. , 1993, Clinical chemistry.

[7]  Jing Gao,et al.  Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. , 2010, International journal of pharmaceutics.

[8]  David R. Olsen,et al.  Stabilization of proteins by recombinant human gelatins. , 2007, Journal of pharmaceutical sciences.

[9]  Jung-Ki Park,et al.  Synthesis and Characterization of Starch-g-Polycaprolactone Copolymer , 1999 .

[10]  Kinam Park,et al.  Insulin-loaded microcapsules for in vivo delivery. , 2009, Molecular pharmaceutics.

[11]  Hsing-Wen Sung,et al.  A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. , 2011, Biomaterials.

[12]  Mark R Prausnitz,et al.  Separable arrowhead microneedles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Desmond I. J. Morrow,et al.  Microneedle‐Mediated Intradermal Delivery , 2012 .

[14]  X. Sun,et al.  Mechanical properties of poly(lactic acid)/starch composites compatibilized by maleic anhydride. , 2004, Biomacromolecules.

[15]  A. Cunha,et al.  Enzymatic degradation of starch-based thermoplastic compounds used in protheses: identification of the degradation products in solution. , 2004 .

[16]  R L Reis,et al.  The biocompatibility of novel starch-based polymers and composites: in vitro studies. , 2002, Biomaterials.

[17]  S. Sajeesh,et al.  Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. , 2006, International journal of pharmaceutics.

[18]  S. Vyas,et al.  Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles , 2011, Drug delivery.

[19]  D. Muchmore,et al.  Inhaled insulin delivery – where are we now? , 2006, Diabetes, obesity & metabolism.

[20]  M. Rekha,et al.  Bioadhesive hydrophobic chitosan microparticles for oral delivery of insulin: In vitro characterization and in vivo uptake studies , 2011 .

[21]  E. Gök,et al.  Binding of Fluorescein Isothiocyanate to Insulin: A Fluorimetric Labeling Study , 2004, Journal of Fluorescence.

[22]  J. Bouwstra,et al.  In vivo assessment of safety of microneedle arrays in human skin. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  Jung-Hwan Park,et al.  Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.

[24]  T. Aminabhavi,et al.  Polymeric hydrogels for oral insulin delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[25]  T. Aminabhavi,et al.  Developments in polymeric devices for oral insulin delivery , 2008, Expert opinion on drug delivery.

[26]  Tejraj M Aminabhavi,et al.  Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[27]  W. Cefalu Concept, strategies, and feasibility of noninvasive insulin delivery. , 2004, Diabetes care.

[28]  Mark R Prausnitz,et al.  Dissolving microneedle patch for transdermal delivery of human growth hormone. , 2011, Small.

[29]  Shih-Fang Huang,et al.  Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. , 2013, Biomaterials.

[30]  L. Chu Controlled release systems for insulin delivery , 2005 .

[31]  Mei-Chin Chen,et al.  Chitosan microneedle patches for sustained transdermal delivery of macromolecules. , 2012, Biomacromolecules.

[32]  Mark R. Prausnitz,et al.  Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.

[33]  Antonios G Mikos,et al.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Maelíosa T. C. McCrudden,et al.  Microneedles for intradermal and transdermal drug delivery. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  T. Aminabhavi,et al.  Poly(N-vinylcaprolactam-co-methacrylic acid) hydrogel microparticles for oral insulin delivery , 2011, Journal of microencapsulation.

[36]  N. Peppas,et al.  In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. , 2003, International journal of pharmaceutics.

[37]  M. Emeje,et al.  Recent applications of starch derivatives in nanodrug delivery , 2012, Carbohydrate Polymers.

[38]  Akira Yamamoto,et al.  The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[39]  V. Lenaerts,et al.  Tissue reaction and biodegradation of implanted cross-linked high amylose starch in rats. , 2002, Journal of biomedical materials research.

[40]  Yoshinori Onuki,et al.  Current challenges in non-invasive insulin delivery systems: a comparative review. , 2007, Advanced drug delivery reviews.

[41]  Rui L Reis,et al.  An in vivo study of the host response to starch-based polymers and composites subcutaneously implanted in rats. , 2005, Macromolecular bioscience.

[42]  Mark R. Prausnitz,et al.  Dissolving Polymer Microneedle Patches for Influenza Vaccination , 2010, Nature Medicine.

[43]  Samantha A. Meenach,et al.  Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions. , 2012, International journal of pharmaceutics.

[44]  M. J. Santander-Ortega,et al.  Nanoparticles made from novel starch derivatives for transdermal drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Hirofumi Takeuchi,et al.  Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  Jung Dong Kim,et al.  A high-capacity, hybrid electro-microneedle for in-situ cutaneous gene transfer. , 2011, Biomaterials.

[47]  T. Aminabhavi,et al.  pH-Sensitive oral insulin delivery systems using Eudragit microspheres , 2011, Drug development and industrial pharmacy.